What We Do
The HudsonAlpha Clinical Services Lab, LLC (CSL) provides testing for those who embark on a personal journey through genomics. The CSL is wholly owned by the HudsonAlpha Institute for Biotechnology, a non-profit research institute committed to advancing genomic knowledge by bringing scientific discoveries into clinical care. The CSL team works to solve undiagnosed diseases and end diagnostic odysseys. Our goal is to provide support that goes beyond the genome, helping resolve uncertainty and seeking answers for symptoms that remain unexplained by DNA sequencing.
CLIA Certification | CAP Accreditation
The HudsonAlpha Clinical Services Lab (CSL) offers a sequencing and interpretation pipeline that is accredited by the College of American Pathologists (CAP) and certified through Clinical Laboratory Improvement Amendments (CLIA).
The CSL does not yet accept samples from New York.
Consistent with Laboratory Developed Tests, CSL’s personalized genomic testing has not been cleared or approved by the U.S. Food and Drug Administration.
CLIA ID #: 01D2086581 | CAP #: 8051488
Clinical Services Lab Team
Our team consists of internationally-revered clinicians, researchers, analysts and informaticians.
Elaine Lyon, PhD, FACMG
David Bick, MD, FACMG
Ghunwa Nakouzi, PhD, FACMG
Genomic Variant Scientist
James Holt (Matt)
Nadiya Sosonkina, PhD
Scientist / Research Associate III
Executive Board of the HudsonAlpha Clinical Services Lab
Officers of the HudsonAlpha Clinical Services Lab